Immunostimulatory Adjuvants
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Glassia 1.2.3 Aralast NP 1.2.4 Prolastin C 1.2.5 Others 1.3 Market by Application 1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2017-2028) 2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region 2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2017-2022) 2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028) 2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics 2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends 2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers 2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges 2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue 3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2017-2022) 3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue 3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio 3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021 3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served 3.6 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service 3.7 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type 4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2017-2022) 4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028) 5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application 5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2017-2022) 5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028) 6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) 6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028) 7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) 7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028) 8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) 8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028) 9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) 9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028) 10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) 10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Grifols 11.1.1 Grifols Company Detail 11.1.2 Grifols Business Overview 11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) 11.1.5 Grifols Recent Development 11.2 CSL 11.2.1 CSL Company Detail 11.2.2 CSL Business Overview 11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) 11.2.5 CSL Recent Development 11.3 Baxter 11.3.1 Baxter Company Detail 11.3.2 Baxter Business Overview 11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) 11.3.5 Baxter Recent Development 11.4 Kamada 11.4.1 Kamada Company Detail 11.4.2 Kamada Business Overview 11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) 11.4.5 Kamada Recent Development 11.5 Takeda 11.5.1 Takeda Company Detail 11.5.2 Takeda Business Overview 11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) 11.5.5 Takeda Recent Development 11.6 Abeona 11.6.1 Abeona Company Detail 11.6.2 Abeona Business Overview 11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction 11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) 11.6.5 Abeona Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Glassia Table 3. Key Players of Aralast NP Table 4. Key Players of Prolastin C Table 5. Key Players of Others Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2022) Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2023-2028) Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players (2017-2022) Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021) Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service Table 23. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2017-2022) Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2023-2028) Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million) Table 43. Grifols Company Detail Table 44. Grifols Business Overview Table 45. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Table 46. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million) Table 47. Grifols Recent Development Table 48. CSL Company Detail Table 49. CSL Business Overview Table 50. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Table 51. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million) Table 52. CSL Recent Development Table 53. Baxter Company Detail Table 54. Baxter Business Overview Table 55. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Table 56. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million) Table 57. Baxter Recent Development Table 58. Kamada Company Detail Table 59. Kamada Business Overview Table 60. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Table 61. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million) Table 62. Kamada Recent Development Table 63. Takeda Company Detail Table 64. Takeda Business Overview Table 65. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Table 66. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million) Table 67. Takeda Recent Development Table 68. Abeona Company Detail Table 69. Abeona Business Overview Table 70. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Table 71. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million) Table 72. Abeona Recent Development Table 73. Research Programs/Design for This Report Table 74. Key Data Information from Secondary Sources Table 75. Key Data Information from Primary Sources List of Figures Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2021 VS 2028 Figure 2. Glassia Features Figure 3. Aralast NP Features Figure 4. Prolastin C Features Figure 5. Others Features Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application in 2021 & 2028 Figure 7. Hospitals Case Studies Figure 8. Specialty Clinics Case Studies Figure 9. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered Figure 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2021 VS 2028 Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2021 Figure 14. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021 Figure 16. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028) Figure 18. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028) Figure 22. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2028) Figure 30. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028) Figure 38. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028) Figure 42. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) Figure 45. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) Figure 46. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) Figure 47. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) Figure 48. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) Figure 49. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed
Grifols CSL Baxter Kamada Takeda Abeona
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Healthcare Architecture Service market is segmented by players, region (country), by Type and by ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Data Integration and Integrity Software market is segmented by players, region (country), by Type ... Read More